Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Last post: Gingerpig, 26 Mar 2023 11:10
Hey, this is the first company that’s de listed on me. I kept my shares and they show up in my trading account albeit of course I can’t trade them. I didn’t request paper share certificates. Thought leave them recorded on my platform may be easier. Is this something I should do? Who would I ask my platform or allied minds direct? Lastly how to we establish what they may be worth and how do we go about trading them? Any help/opinions appreciated
Tuesday 29 November
When is scheduled to delist?
I note, having looked at the Circular again, that consideration is being given to arranging a matched bargain facility. Expect the shares to rally should this be confirmed before delisting.
I would regard the situation as similar to a company going into voluntary liquidation [most definitely not a liquidation due to solvency issues]. The shares will probably still be displayed on your account at book cost but nil value. It is very important to read the corporate action statement from the broker, especially if held in an ISA, as they would have to be transferred out. I'm not sure if they are planning to cancel the CREST facility, but if they are, they will sent paper certificates to be held by your broker.
It also appears that there are no plans to set up a matched bargain facility, so it will be impossible monetise your holding at will.
The plan is to liquidate the holding over a medium term period [18-24 months]. As they do this, they should make returns of capital, which of course will be credited to your account as and when.
In my opinion there is massive value on offer here at the current SP for the patient investor [just look at the PDMR dealings]. I think a 30p total return is a possibility, but I would still be more than happy with double the current SP [9p offer] as I write.
I suspect a lot of people hold these in an ISA and are worried about what happens after delisting so have become forced sellers.
Correct me if i'm wrong but after delisting it would be difficult to monitise your holding. If I was holding I would be selling pretty darn fast. But please DYOR and this is only my uneducated view, which may be wrong
Hi, please can someone in the know explain to a simpleton like myself if I held the share after it delist how will I be able to monetise it in the future? Thank you for your help
Sorry. Of course it had put itself up for sale. Managed to forget that!
Why the above starting to come in. I assume to do with potential delisting but still ‘potential’ atm?
They have circa 9m cash so would not be able to continue to be listed. Alm is around 75% institutionally held so yes they must be onboard. PI’s don’t generally vote in the Agm’s and if you look at the voting pattern, it matches the institutional holdings for votes against remuneration. My take is they back the delist but not the remuneration package directors want. Effectively they do f#ck all as the subsidiaries run themselves.
Companies generally sound out larger holders before any major decisions.
Delisting is not actually bad. Anyone still holding now ain’t selling anyway so what’s the difference. Cash will be returned to shareholders as and when the various subsidiaries are liquidated.
Agree - Crystal Amber will need to something here. Maybe buy more shares and take action.
I would presume they already have the backing of the institutions. Not sure on the numbers for this but guess they would need 75% support to delist.
At the end of the day they have circa $9mill in cash and £6 mill running costs so would not be allowed to stay listed anyway.
Hopefully the remaining $ can be used to support financing for orbital. Give it another year and those that haven’t sold now should be rewarded. GLA
I’m surprised this did not drop further!
they will probably end up being traded privately which overall means you'll struggle to get anything decent for them even if you can find another buyer wanting them - i write off any shares which delist in the past though my holdings were minimal
i;m guessing there's a big sell in the background as there's no movement.
Started: Scarfell, 24 Aug 2022 10:36
Last post: Scarfell, 24 Aug 2022 10:36
Yet another dud from IC/ST. Subscribing (in the past) to that mag has cost me a lot.
Started: HeadingNorth, 24 Aug 2022 09:52
Last post: hellyeah, 24 Aug 2022 10:03
Really disappointing. They have some good assets but absolutely rubbish BOD. Considering reporting them to FRC for this farce!
40% drop ! Absolute dog of a company. Totally mismanaged.
So do we think these are good addition?
Started: HeadingNorth, 12 Jun 2022 09:35
Last post: HeadingNorth, 12 Jun 2022 09:35
This company & share price have taken a real battering under the appalling leadership of Mark & Harry, not to mention the damage done by the scandalous Neil Woodford.
Glad I sold out ages ago, but sadly even with new leadership it could take a couple of years to bed in new culture, and get real meaningful change to help the share price recover. Good luck to anyone still holding here.
Started: Dungiven123, 23 Mar 2022 22:19
Last post: Gazelleman, 31 Mar 2022 17:59
That's it. Harry has thrown in the towel and Crystal Amber have got their way - see the RNS.
Placed my vote today via the broker. Went with CA.
Started: pablo_escobar, 9 Mar 2022 20:51
Last post: pablo_escobar, 10 Mar 2022 13:24
I’m on the fence till CA communicate a plan.
Will vote with CA on this one.
They never mentioned or addressed why they said fw was a up value for fundraising when it was not. This was one of ca points.
All I want is share price to rise and effect m true value. As now up for sale, will be interesting to see what value market puts on it if any!
Started: Funji, 21 Feb 2022 09:51
Last post: ripley94, 23 Feb 2022 13:15
It was an impressive move with HUR , CRS seem on the ball .
Looks like a good move. Interesting comment there about an accidental press release from FW stating they had exceeded revenue forecasts by four times.
Crystal Amber Fund requisitions General Meeting of Allied Minds plc to propose the removal of the Chairman, Harry Rein, as a director.
https://www.investegate.co.uk/crystal-amber-fund/rns/crystal-amber-requisitions-gm-of-allied-minds-plc/202202181515351800C/
Started: pablo_escobar, 12 Jan 2022 09:15
Last post: pablo_escobar, 14 Jan 2022 12:14
Agreed. Comms is very poor. Waiting on Aurora launch for orbital giving an additional revenue stream. Bc are busy but website not updated regularly. They are also Rev producing.
https://24activenews.com/2021/10/05/hyspeciq-and-bridgecomm-join-together-for-hi-speed-optical-downlinks/
https://spacenews.com/bridgecomm-space-micro-deal-2021/
https://news.satnews.com/2021/09/09/optical-inter-satellite-links-now-offered-by-bridgecomm-to-customers/
A great example of the lack of communication/effort is that Spark Insights is listed as a portfolio company on the AlliedMinds web site. That was sold 2 1/2 months ago , well more accurately it was swapped for Concirrus stock. Concirrus now own Spark. So why aren't Concirrus listed? Why isn't there an RNS espousing the exciting opportunity with Concirrus? In the spirit of providing information via this forum here's their website: https://www.concirrus.ai/ - impressive client list and exciting product that has the potential to disrupt the market.
Pablo - take a look at the portfolio's web sites. My take on where they are:
1. Federated Wireless - completely revamped their web site - looks very slick - looks the part, and in fact appears very encouraging. In line with expectations that this one will come good during 2022.
2. BridgeComm - out of date links, no new news since 2020. I see there's news not reported on their web site e.g.
https://www.businesswire.com/news/home/20210401005281/en/BridgeComm-Will-Commence-Targeted-Customer-Demos-of-Ultra-Broadband-Speeds-Surpassing-100GB-per-Second
Disappointing..... however that link of their latest news looks encouraging. In my opinion BridgeComm are nowhere near an IPO in 2022 - based on appearances.
3. Orbital Sidekick - again a very professional and slick web site and the last news is last summer's launch. There was meant to be a launch of a further 6 (?) Aurora satellites in early 2022. But there's no mention of this.
This video/interview is impressive:
https://orbitalsidekick.com/orbital-sidekicks-aurora-satellite-uses-technology-towards-a-sustainable-future/
It's the sort of business you want to succeed but again I don't see any tangible evidence of a 2022 IPO so my guess would be this is going to be 2023 earliest.
AlliedMinds web site? RNS updates? No! Poor communication - you get more updates from following this forum!
News on federated must be soon as well as bridgecomm. Looking for a substantial uplift on both. Last raise in 2019 fed valued at 26p to ALM and BC 8p. Both now revenue producing and market leaders.
Started: preciousmaj, 24 Nov 2021 09:16
Last post: Dungiven123, 24 Nov 2021 20:06
I think the problem is the issue that CA is having. Read his last report. His Fund lost a vote and looks like will have to wind up and he has said that the 2 funds that hold 30% of his fund have large shorts on alm and de la rue and r using his fund as a hedge to their position. CA have said they will respond within next few weeks about what they r going to do.
I presume the share price will continue to drift until we get a further update in relation to Federated Wireless IPO or another funding round. It would be nice to have an actual timeline from the ALM Board without giving sensitive information away or is that too much to ask for? Something like we need to tick these boxes before FW can list would be sufficient.
Started: preciousmaj, 8 Nov 2021 09:48
Last post: preciousmaj, 18 Nov 2021 12:50
Disappointed to learn of the 12.8% Fully-Diluted interest in OcuTerra Therapeutics but probably for the best as ALM Board wants to wind down holdings. Post-Money Valuation is $49.5 million and our interest is valued at around $6.3m now.
ALM’s holding in occuterra is 12.8%. We did not participate in the funding round hence the huge dilution. Harry Rein wrote the company off valuing it at 0 despite his “experience in life sciences “. Subsequently Occuterra raised 35mill and attracted big hitters in the life sciences market.
This is all in the half yearly report.
Feds last fund raise valued at 215 mill largely pre revenue. They now have double digit revenue and looking for high double digit next year. New funding round imminent and will be disappointing to see a new fund raise if less than 500mill based on current and projected near term revs.
Yes communication is shocking
We don't know the details and should have had an RNS advising of the fund raise.
If there was dilution to our holding or if ALM participated in the fund raise we should be told via RNS.
What was is the dilution to ALM for the funds raised? Did they take part in the fund raising? U would have though a rns would have been made about this!
Started: preciousmaj, 10 Nov 2021 10:40
Last post: preciousmaj, 10 Nov 2021 10:41
“OTT166 offers potential significant benefit for patients, caregivers and eye care practitioners by providing a non-invasive treatment option for people suffering from diabetic retinopathy,” said Carl Regillo, M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University. “In addition to fulfilling the unmet need of offering a non-invasive treatment option, which would be acceptable to more patients, OTT166 can potentially be administered earlier than eye injections, which may prevent severe disease progression and functional vision loss. I am compelled by the early data and believe that OTT166 has the potential to transform the standard of care for patients with this disease.”
OcuTerra Expands Scientific Advisory Board
OcuTerra also announced the appointment of Paul M. Karpecki, OD, FAAO to its Scientific Advisory Board.
“We are delighted to have Dr. Karpecki join our Scientific Advisory Board as we move forward with the development of OTT166,” said David Tanzer, M.D., ophthalmologist and Chief Medical Officer of OcuTerra. “Paul is a leader and pioneer in the eye care field, and his commitment to innovation aligns with our mission to change the standard of care for the treatment of diabetic eye disease.”
“I am thrilled to join the Scientific Advisory Board of OcuTerra and represent the voice of Doctors of Optometry who manage over 70% of all patients with diabetic retinopathy in the U.S.,” said Dr. Karpecki. “Working closely with my fellow advisors from the retina and anterior segment ophthalmology communities, I am very excited about the development of OTT166, a topical drug candidate to prevent diabetic retinopathy disease progression and loss of visual function.”
Dr. Karpecki received his Doctor of Optometry degree from Indiana University and completed a Durrie Fellowship in Medical Cornea/Refractive Surgery in Kansas City in affiliation with the Pennsylvania College of Optometry. In 2017-2018 he completed a full year preceptorship in advanced retinal disease at Retina Associates of Kentucky, one of the top 20 retina practices in the country. He currently serves as Director of Cornea and External Disease for the Kentucky Eye Institute in Lexington KY. Dr. Karpecki is the Chief Clinical Editor for Review of Optometry, the most read journal in the profession, and chairman of the New Technology and Treatment Conferences. He is Medical Director for KEPLR Vision and Director of Cornea and External Disease for the Center for Sight in Carmel, IN. He was appointed to the Delphi International Society at Wilmer Johns Hopkins which included the top 25 dry eye experts in the world and co-chair for the previous two Tear Film and Ocular Surface Society Symposia. Dr. Karpecki served on the DEWS II Diagnostic Methodology Committee. He is also an Associate Professor at the Kentucky College of Optometry in Pikeville, KY and serves on the board of the charitable organization Optometry
OcuTerra Raises $35 Million Series B Financing
OTT166 DR-EAM Phase 2 Study Expected to Commence Early 2022
Paul Karpecki, OD, FAAO, Appointed to Scientific Advisory Board
November 09, 2021 06:00 AM Eastern Standard Time
BOSTON--(BUSINESS WIRE)--OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology company developing innovative drugs to treat ophthalmic diseases for which the current standard of care of “watch and wait” does not prevent or control the progression of disease, today announced the final close of a $35 million Series B financing. Proceeds will support the DR-EAM (Diabetic Retinopathy - Early Active Management) Phase 2 study of OTT166 in patients with moderate to severe non-proliferative and mild proliferative diabetic retinopathy. The study is expected to commence early next year.
Phase 1b clinical trials of OTT166 eye drops in patients with diabetic retinopathy and wet AMD have demonstrated safety, tolerability and clear clinical evidence of biological activity. OTT166 is a novel small molecule selective integrin inhibitor that OcuTerra has purpose engineered to have the required physiochemical characteristics to be able to reach the retina from eye drop application. Designed to be administered by the patient at home, OTT166 has the potential to dramatically change the treatment paradigm by enabling earlier, non-invasive treatment to preserve vision and prevent progression, thereby delaying or completely eliminating the need for intravitreal injections.
“OcuTerra is well-positioned to transform the treatment landscape for diabetic retinopathy, the leading cause of vision loss and blindness in working age adults in America,” said Kerrie Brady, Chief Executive Officer of OcuTerra. “The current standard of care for these patients is ‘watch and wait’ until vision deteriorates due to diabetic macular edema or the disease progresses to the proliferative form, at which point medically intensive and invasive eye injections and/or laser treatments are instituted. Our mission is to transform the standard of care with OTT166 to offer a non-invasive, easy to administer, effective treatment that can be prescribed earlier in the disease course by a broader range of eye care providers to avoid sight threatening complications, stop disease progression and potentially avoid invasive treatments. We look forward to evaluating OTT166 in Phase 2 trials beginning early next year.”
CONT...
Started: pablo_escobar, 8 Nov 2021 14:35
Last post: pablo_escobar, 8 Nov 2021 14:35
The post the board put out failed to mention 4x expected revenue for federated. “ The last year has seen 4 times the company’s expected revenue growth, its customer and partner base expand rapidly into new verticals, and the number of active CBRS devices grow to more than 70,000. https://www.globenewswire.com/news-release/2021/11/05/2328739/0/en/UPDATE-Federated-Wireless-Accelerates-Leadership-in-Shared-Spectrum-Market.html
Started: pablo_escobar, 19 Oct 2021 23:52
Last post: JMarsh1, 8 Nov 2021 07:22
This board seems quite dead. Advfn’s board has more activity if peeps want to catch up
Started: Echo1, 19 Aug 2021 11:30
Last post: Agricore, 29 Aug 2021 18:41
I appreciate ALM have written off their investment in Spin but we don't yet know what the final status of Spin Memory will be.... ARM are not an insignificant backer of Spin and perhaps the IP is worth something. Perhaps worth quite a lot? Spin did "tape out" their demonstration module so clearly achieved something. If they have a way through Moore's Law (as the theory was set out to be) that provide faster/better semiconductors that could be attractive. Semiconductors aren't exactly a dying industry are they?
We will see.
Well at least the board are buying at least some shares.
The SP does appear stuck in this 24-26p range at present
Plenty who bought at 20p will be selling i reckon
Hopefully we can crack 30p in the next few weeks
GLA
Started: Agricore, 11 Aug 2021 08:32
Last post: dnwill, 18 Aug 2021 20:48
Be careful with your maths. Allied referring to a VC like return would relate to their own investment in Federated. From what I can see, they have invested around $25m in total, thus a 3x return would be $75m which is more or less what their stake was worth at the last investment round.
So they could quite easily claim "VC like returns" by simply exiting Federated in full at the same price as the last round - which would net about 24p per share of ALM.
If the rest of the portfolio is worthless (Federated and Spin were the two big plays and now Spin has spun down the toilet) then the current share price is reflective of NAV.
Hi Echo1
The marine base is worth $12m (probably split $4m in 2021 and $8m in 2022.)
There’s lots of those deals out there and their technology is important for autonomous vehicles, Warehousing and iot. All very topical areas. I wonder whether the likes of Kathie Wood will snap this up in ark invest at some point?
https://federatedwireless.com/federated-wireless-oversees-successful-12-million-5g-private-network-pilot-using-shared-spectrum-for-united-states-department-of-defense/
The NAV assuming we get zero for spin memory (which seems unlikely although their creditors will get the priority) is about 38p
If we assume “VC like returns” being 3x NAV then this as the potential to be a 5 bagger if the whole portfolio exits successfully…..
At current price a patient investor should be rewarded. But I agree the comms from ALM to shareholders are poor. OSK launched its satellite over a month ago. Why sit on the news till today?
Good luck and stay patient!
Evening Agricore
Good to see an update from ALM. Keeping investors in the loop should be one of there top priorities.
Federated Wireless - shaping up to be the saving grace of the BOD. I think it'll become bigger than the whole of the portfolio given time
Bridgecomm and orbital sidekick look like theyre also shaping up very nicely.
And there's some promise in Occutherapeutics too
And a steady rise in the SP is also very welcome!! fingers crossed the NAV is realised in time
The phrase “increasingly confident in delivering venture capital like returns” (typically vc returns are 3x or more) in today’s update is Very good to hear.
Would be good to see fInancial results but the verbal progress update is positive.
Nice to see a little bit of sentiment returning following the update.
Although that’ll be the kiss of death now :-0
Discount to NAV is improving I’d say, fed will start generating $$ Q4
GLA!!
Good to hear Nuck
I’m heading up to skye in October
I’m good mate, chucked some cash into crypto and see where it takes me in a year or two. I’m due a break if I do say so myself. like to check in in ALM SP as you know. In Aviemore at the moment. A weeks holiday from the grind and a different kitchen sink.
Sorry Nuck - only just spotted your reply.
I'm holding off on new investments for the time being - made plenty of ££ last 15 months so I'm happy just to sit on what I've got
You doing ok?
Echo, you not fancy selling up and taking advantage of the current crypto crash?
Some very hefty trades have gone through in the last few days
One for £1 million and a second for £372K
There seems to be resistance at 20-21p
Maybe that's the end of the downward pressure?
Happy to hear opinions of this lame donkey lol
Started: Agricore, 31 Jul 2021 09:06
Last post: Agricore, 2 Aug 2021 07:53
Hi Echo, The 5G roll out is a key enabler for a number of technologies (autonomous vehicles, IOT, space tech) so anticipate this share becoming a "hot" area - and a "picks and shovels" play.
I think each of the portfolio has good potential - and once a funding round or an IPO is announced then the current 20p is a total bargain. So I'm very happy to be in here at this price. Just this morning my investment in Thinksmart is going to shoot up on the news the Dorsey is buying Clearpay..... well I'm assuming it shall.... the market opens in an hour!
Morning Agricore,
thanks for posting those. Not sure what your thinking is but I'm very hopeful we'll start to see significant revenues from Federated Wireless from Q4 2021 onwards. Federated is the only reason I've stayed invested here - I genuinely think it could grow to be far bigger than the whole of ALM portfolio in time.
What were your thoughts?
https://www.ravepubs.com/wireless-sees-the-light/
Meanwhile at ALM 2nd portfolio in 5G - the market opportunity is significant and imminent:
“Traditionally, optical wireless communications is from a transmitter to a receiver, point-to-point, and that was it. That obviously limits its applicability. Whereas we have developed the ability to do point-to-multipoint communications (something we term one-to-many communications). This acts very much like RF so we can support a multitude of parties with much higher bandwidth. That means that applications like mobility, being able to support end users as they travel and track them is part of our capability we’re developing.”
“In terms of applicability to infrastructure, we’re not that far away at all. We were already having discussions and demonstrations with commercial carriers, mobile carriers, mobile and fixed carriers. And I can see that they have already started adopting product to put in place early next year (2022).”
Started: Agricore, 31 Jul 2021 08:58
Last post: Agricore, 31 Jul 2021 08:58
https://www.fiercewireless.com/private-wireless/lte-dominates-private-networks-but-5g-coming-special-report
There are a lot of advantages that come with 5G. 5G is cloud native, and it’s designed with IT principles in mind; therefore, it’s simple for enterprise IT staff to deploy, operate and support.
As for what impact the pandemic is having on private networks, “it’s a double-edged sword,” Dhar said. On one hand, some 3GPP standards work slowed down because it takes longer to resolve conflicts in a virtual world versus in-person meetings.
On the other hand, the pandemic increased the desire on the part of some enterprises to automate rather than have people be physically close to one another. If the pandemic has brought anything to light, “it’s basically the urgency for every industry and every enterprise to accelerate their digitization process,” Dhar said.
5G is not a great deal more expensive than 4G and brings with it a strong Industrial IoT feature set, including enhanced Mobile Broadband (eMBB), Ultra Reliable Low Latency Communication (URLLC) and massive Machine Type Communications (MTC), according to Dhar.
Federated Wireless expects 5G will be commercially deployed on CBRS in the fourth quarter of this year. The company, which runs a Spectrum Access System (SAS), is involved in 5G trials with customers, and it’s also deploying 5G for the Department of Defense (DoD).